Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Commentary on "Mandible exosomal ssc-mir-133b regulates tooth development in miniature swine via endogenous apoptosis".

Puzas JE.

Bone Res. 2018 Oct 17;6:29. doi: 10.1038/s41413-018-0033-8. eCollection 2018. No abstract available.

2.

The effects of high-dose calcitriol and individualized exercise on bone metabolism in breast cancer survivors on hormonal therapy: a phase II feasibility trial.

Peppone LJ, Ling M, Huston AJ, Reid ME, Janelsins MC, Puzas JE, Kamen C, Del Giglio A, Asare M, Peoples AR, Mustian KM.

Support Care Cancer. 2018 Aug;26(8):2675-2683. doi: 10.1007/s00520-018-4094-4. Epub 2018 Feb 22.

3.

Multivalent Presentation of Peptide Targeting Groups Alters Polymer Biodistribution to Target Tissues.

Newman MR, Russell SG, Schmitt CS, Marozas IA, Sheu TJ, Puzas JE, Benoit DSW.

Biomacromolecules. 2018 Jan 8;19(1):71-84. doi: 10.1021/acs.biomac.7b01193. Epub 2017 Dec 28.

4.

Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing.

Wang Y, Newman MR, Ackun-Farmmer M, Baranello MP, Sheu TJ, Puzas JE, Benoit DSW.

ACS Nano. 2017 Sep 26;11(9):9445-9458. doi: 10.1021/acsnano.7b05103. Epub 2017 Sep 13.

5.

Sclerostin activity plays a key role in the negative effect of glucocorticoid signaling on osteoblast function in mice.

Beier EE, Sheu TJ, Resseguie EA, Takahata M, Awad HA, Cory-Slechta DA, Puzas JE.

Bone Res. 2017 May 9;5:17013. doi: 10.1038/boneres.2017.13. eCollection 2017.

6.

Elevated Lifetime Lead Exposure Impedes Osteoclast Activity and Produces an Increase in Bone Mass in Adolescent Mice.

Beier EE, Holz JD, Sheu TJ, Puzas JE.

Toxicol Sci. 2016 Feb;149(2):277-88. doi: 10.1093/toxsci/kfv234. Epub 2015 Oct 30.

7.

Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/β-CATENIN SIGNALING PATHWAY.

Beier EE, Sheu TJ, Dang D, Holz JD, Ubayawardena R, Babij P, Puzas JE.

J Biol Chem. 2015 Jul 17;290(29):18216-26. doi: 10.1074/jbc.M114.629204. Epub 2015 May 14.

8.

Effects of Combined Exposure to Lead and High-Fat Diet on Bone Quality in Juvenile Male Mice.

Beier EE, Inzana JA, Sheu TJ, Shu L, Puzas JE, Mooney RA.

Environ Health Perspect. 2015 Oct;123(10):935-43. doi: 10.1289/ehp.1408581. Epub 2015 Apr 10.

9.

Inhibition of beta-catenin signaling by Pb leads to incomplete fracture healing.

Beier EE, Sheu TJ, Buckley T, Yukata K, O'Keefe R, Zuscik MJ, Puzas JE.

J Orthop Res. 2014 Nov;32(11):1397-405. doi: 10.1002/jor.22677. Epub 2014 Jul 21.

10.

Heavy metal lead exposure, osteoporotic-like phenotype in an animal model, and depression of Wnt signaling.

Beier EE, Maher JR, Sheu TJ, Cory-Slechta DA, Berger AJ, Zuscik MJ, Puzas JE.

Environ Health Perspect. 2013 Jan;121(1):97-104. doi: 10.1289/ehp.1205374. Epub 2012 Oct 19. Erratum in: Environ Health Perspect. 2013 Feb;121(2):a43.

11.

Influence of upper extremity assistance on lower extremity force application symmetry in individuals post-hip fracture during the sit-to-stand task.

Kneiss JA, Houck JR, Bukata SV, Puzas JE.

J Orthop Sports Phys Ther. 2012 May;42(5):474-81. doi: 10.2519/jospt.2012.3562. Epub 2012 Apr 30.

PMID:
22565360
12.

Lead induces an osteoarthritis-like phenotype in articular chondrocytes through disruption of TGF-β signaling.

Holz JD, Beier E, Sheu TJ, Ubayawardena R, Wang M, Sampson ER, Rosier RN, Zuscik M, Puzas JE.

J Orthop Res. 2012 Nov;30(11):1760-6. doi: 10.1002/jor.22117. Epub 2012 Apr 19.

13.

TRIP-1: a regulator of osteoblast function.

Metz-Estrella D, Jonason JH, Sheu TJ, Mroczek-Johnston RM, Puzas JE.

J Bone Miner Res. 2012 Jul;27(7):1576-84. doi: 10.1002/jbmr.1611.

14.

Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis.

Sampson ER, Hilton MJ, Tian Y, Chen D, Schwarz EM, Mooney RA, Bukata SV, O'Keefe RJ, Awad H, Puzas JE, Rosier RN, Zuscik MJ.

Sci Transl Med. 2011 Sep 21;3(101):101ra93. doi: 10.1126/scitranslmed.3002214.

15.

Analysis of vertical ground reaction force variables during a Sit to Stand task in participants recovering from a hip fracture.

Houck J, Kneiss J, Bukata SV, Puzas JE.

Clin Biomech (Bristol, Avon). 2011 Jun;26(5):470-6. doi: 10.1016/j.clinbiomech.2010.12.004. Epub 2010 Dec 31.

16.

Orthopedic uses of teriparatide.

Bukata SV, Puzas JE.

Curr Osteoporos Rep. 2010 Mar;8(1):28-33. doi: 10.1007/s11914-010-0006-3. Review.

PMID:
20425088
17.

Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice.

Yan Y, Tang D, Chen M, Huang J, Xie R, Jonason JH, Tan X, Hou W, Reynolds D, Hsu W, Harris SE, Puzas JE, Awad H, O'Keefe RJ, Boyce BF, Chen D.

J Cell Sci. 2009 Oct 1;122(Pt 19):3566-78. doi: 10.1242/jcs.051904. Epub 2009 Sep 8.

18.

Putative signaling action of amelogenin utilizes the Wnt/beta-catenin pathway.

Matsuzawa M, Sheu TJ, Lee YJ, Chen M, Li TF, Huang CT, Holz JD, Puzas JE.

J Periodontal Res. 2009 Jun;44(3):289-96.

PMID:
19462488
19.

Reduced COX-2 expression in aged mice is associated with impaired fracture healing.

Naik AA, Xie C, Zuscik MJ, Kingsley P, Schwarz EM, Awad H, Guldberg R, Drissi H, Puzas JE, Boyce B, Zhang X, O'Keefe RJ.

J Bone Miner Res. 2009 Feb;24(2):251-64. doi: 10.1359/jbmr.081002.

20.

Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice.

Wu Q, Kim KO, Sampson ER, Chen D, Awad H, O'Brien T, Puzas JE, Drissi H, Schwarz EM, O'Keefe RJ, Zuscik MJ, Rosier RN.

Arthritis Rheum. 2008 Oct;58(10):3132-44. doi: 10.1002/art.23946.

21.

Spinal interleukin-1beta in a mouse model of arthritis and joint pain.

Fiorentino PM, Tallents RH, Miller JN, Brouxhon SM, O'Banion MK, Puzas JE, Kyrkanides S.

Arthritis Rheum. 2008 Oct;58(10):3100-9. doi: 10.1002/art.23866.

22.

Erythropoietin accelerates functional recovery after peripheral nerve injury.

Elfar JC, Jacobson JA, Puzas JE, Rosier RN, Zuscik MJ.

J Bone Joint Surg Am. 2008 Aug;90(8):1644-53. doi: 10.2106/JBJS.G.00557.

23.

The cranial base in craniofacial development: a gene therapy study.

Kyrkanides S, Kambylafkas P, Miller JH, Tallents RH, Puzas JE.

J Dent Res. 2007 Oct;86(10):956-61.

PMID:
17890671
24.

Lead induces chondrogenesis and alters transforming growth factor-beta and bone morphogenetic protein signaling in mesenchymal cell populations.

Zuscik MJ, Ma L, Buckley T, Puzas JE, Drissi H, Schwarz EM, O'Keefe RJ.

Environ Health Perspect. 2007 Sep;115(9):1276-82.

25.

Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity.

Li D, Gromov K, Søballe K, Puzas JE, O'Keefe RJ, Awad H, Drissi H, Schwarz EM.

J Orthop Res. 2008 Jan;26(1):96-105.

26.

Environmental toxicants may modulate osteoblast differentiation by a mechanism involving the aryl hydrocarbon receptor.

Ryan EP, Holz JD, Mulcahey M, Sheu TJ, Gasiewicz TA, Puzas JE.

J Bone Miner Res. 2007 Oct;22(10):1571-80.

27.

Environmental agents affect skeletal growth and development.

Holz JD, Sheu TJ, Drissi H, Matsuzawa M, Zuscik MJ, Puzas JE.

Birth Defects Res C Embryo Today. 2007 Mar;81(1):41-50. Review.

PMID:
17539012
28.

Amelioration of pain and histopathologic joint abnormalities in the Col1-IL-1beta(XAT) mouse model of arthritis by intraarticular induction of mu-opioid receptor into the temporomandibular joint.

Kyrkanides S, Fiorentino PM, Miller JN, Gan Y, Lai YC, Shaftel SS, Puzas JE, Piancino MG, O'Banion MK, Tallents RH.

Arthritis Rheum. 2007 Jun;56(6):2038-48.

29.

Natural calcium isotopic composition of urine as a marker of bone mineral balance.

Skulan J, Bullen T, Anbar AD, Puzas JE, Shackelford L, LeBlanc A, Smith SM.

Clin Chem. 2007 Jun;53(6):1155-8. Epub 2007 Apr 26.

30.

Accelerated fracture healing.

Puzas JE, Houck J, Bukata SV.

J Am Acad Orthop Surg. 2006;14(10 Spec No.):S145-51. Review.

PMID:
17003188
31.

Intraarticular induction of interleukin-1beta expression in the adult mouse, with resultant temporomandibular joint pathologic changes, dysfunction, and pain.

Lai YC, Shaftel SS, Miller JN, Tallents RH, Chang Y, Pinkert CA, Olschowka JA, Dickerson IM, Puzas JE, O'Banion MK, Kyrkanides S.

Arthritis Rheum. 2006 Apr;54(4):1184-97.

32.

Molecular correlates of site-specific metastasis.

Dai CY, Haqq CM, Puzas JE.

Semin Radiat Oncol. 2006 Apr;16(2):102-10. Review.

PMID:
16564445
33.

Lead exposure inhibits fracture healing and is associated with increased chondrogenesis, delay in cartilage mineralization, and a decrease in osteoprogenitor frequency.

Carmouche JJ, Puzas JE, Zhang X, Tiyapatanaputi P, Cory-Slechta DA, Gelein R, Zuscik M, Rosier RN, Boyce BF, O'Keefe RJ, Schwarz EM.

Environ Health Perspect. 2005 Jun;113(6):749-55.

34.

Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone.

Gordon AH, O'Keefe RJ, Schwarz EM, Rosier RN, Puzas JE.

Cancer Res. 2005 Apr 15;65(8):3209-17.

35.

The role of Axin2 in calvarial morphogenesis and craniosynostosis.

Yu HM, Jerchow B, Sheu TJ, Liu B, Costantini F, Puzas JE, Birchmeier W, Hsu W.

Development. 2005 Apr;132(8):1995-2005.

36.

Biology and pathology of the temporomandibular joint: is there an animal model to study this affliction?

Puzas JE.

J Musculoskelet Neuronal Interact. 2003 Dec;3(4):395-400; discussion 406-7. No abstract available.

37.

Pharmacologic modulators of fracture healing: the role of cyclooxygenase inhibition.

Puzas JE, O'Keefe RJ, Schwarz EM, Zhang X.

J Musculoskelet Neuronal Interact. 2003 Dec;3(4):308-12; discussion 320-1. No abstract available.

38.

The association between environmental lead exposure and bone density in children.

Campbell JR, Rosier RN, Novotny L, Puzas JE.

Environ Health Perspect. 2004 Aug;112(11):1200-3.

39.

Transforming growth factor-beta1 induced alteration of skeletal morphogenesis in vivo.

Ferguson CM, Schwarz EM, Puzas JE, Zuscik MJ, Drissi H, O'Keefe RJ.

J Orthop Res. 2004 Jul;22(4):687-96.

40.

Primary murine limb bud mesenchymal cells in long-term culture complete chondrocyte differentiation: TGF-beta delays hypertrophy and PGE2 inhibits terminal differentiation.

Zhang X, Ziran N, Goater JJ, Schwarz EM, Puzas JE, Rosier RN, Zuscik M, Drissi H, O'Keefe RJ.

Bone. 2004 May;34(5):809-17.

PMID:
15121012
41.

5-azacytidine alters TGF-beta and BMP signaling and induces maturation in articular chondrocytes.

Zuscik MJ, Baden JF, Wu Q, Sheu TJ, Schwarz EM, Drissi H, O'Keefe RJ, Puzas JE, Rosier RN.

J Cell Biochem. 2004 May 15;92(2):316-31.

PMID:
15108358
42.

CREB Cooperates with BMP-stimulated Smad signaling to enhance transcription of the Smad6 promoter.

Ionescu AM, Drissi H, Schwarz EM, Kato M, Puzas JE, McCance DJ, Rosier RN, Zuscik MJ, O'Keefe RJ.

J Cell Physiol. 2004 Mar;198(3):428-40.

PMID:
14755548
43.

PGE2 and IL-6 production by fibroblasts in response to titanium wear debris particles is mediated through a Cox-2 dependent pathway.

Bukata SV, Gelinas J, Wei X, Rosier RN, Puzas JE, Zhang X, Schwarz EM, Song XY, Griswold DE, O'Keefe RJ.

J Orthop Res. 2004 Jan;22(1):6-12.

44.

Runx2/Cbfa1 stimulation by retinoic acid is potentiated by BMP2 signaling through interaction with Smad1 on the collagen X promoter in chondrocytes.

Drissi MH, Li X, Sheu TJ, Zuscik MJ, Schwarz EM, Puzas JE, Rosier RN, O'Keefe RJ.

J Cell Biochem. 2003 Dec 15;90(6):1287-98.

PMID:
14635200
45.

NFkappaB: a pivotal transcription factor in prostate cancer metastasis to bone.

Andela VB, Gordon AH, Zotalis G, Rosier RN, Goater JJ, Lewis GD, Schwarz EM, Puzas JE, O'Keefe RJ.

Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S75-85. Review.

PMID:
14600595
46.

ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development.

Zhang D, Schwarz EM, Rosier RN, Zuscik MJ, Puzas JE, O'Keefe RJ.

J Bone Miner Res. 2003 Sep;18(9):1593-604.

47.

Smad6 is induced by BMP-2 and modulates chondrocyte differentiation.

Li X, Ionescu AM, Schwarz EM, Zhang X, Drissi H, Puzas JE, Rosier RN, Zuscik MJ, O'Keefe RJ.

J Orthop Res. 2003 Sep;21(5):908-13.

48.

ATF-2 cooperates with Smad3 to mediate TGF-beta effects on chondrocyte maturation.

Ionescu AM, Schwarz EM, Zuscik MJ, Drissi H, Puzas JE, Rosier RN, O'Keefe RJ.

Exp Cell Res. 2003 Aug 1;288(1):198-207.

PMID:
12878171
49.

Pretreatment of bone with osteoclasts affects phenotypic expression of osteoblast-like cells.

Boyan BD, Schwartz Z, Lohmann CH, Sylvia VL, Cochran DL, Dean DD, Puzas JE.

J Orthop Res. 2003 Jul;21(4):638-47.

50.

Retinoic acid stimulates chondrocyte differentiation and enhances bone morphogenetic protein effects through induction of Smad1 and Smad5.

Li X, Schwarz EM, Zuscik MJ, Rosier RN, Ionescu AM, Puzas JE, Drissi H, Sheu TJ, O'Keefe RJ.

Endocrinology. 2003 Jun;144(6):2514-23.

PMID:
12746314

Supplemental Content

Loading ...
Support Center